Germany's R&D tax incentive enters 2026 in its most generous form yet: a higher assessment base, a higher hourly rate and a new flat-rate overhead allowance. Any company engaged in development — from machinery manufacturers to software houses — that fails to claim the allowance is giving away predictable liquidity. Because it is paid out regardless of whether the company makes a profit.

What the research allowance is — and what it is not

Since 2020, the Research Allowance Act (FZulG) has provided a tax-based incentive for basic research, industrial research and experimental development. Unlike project grant programmes, it involves no funding competition and no submission deadlines before a project begins: there is a legal entitlement, and claims can be filed retroactively for up to four years. The allowance is credited against the company's tax liability — and for loss-making companies it is paid out in cash. For start-ups and investment-heavy development phases in particular, this makes it effectively a subsidy with real cash impact.

The terms since 1 January 2026

A practical benchmark

A development team with €1m in eligible personnel costs generates, including the 20% overhead allowance, an assessment base of €1.2m — that is €300,000 in allowance per year, or €420,000 as an SME. Every year, verifiable retroactively for up to four years.

The two-stage procedure

Stage 1 — BSFZ certificate: The Research Allowance Certification Office (BSFZ) assesses whether the project qualifies in principle (novelty, technical uncertainty, systematic approach). Applications are project-specific and can also be filed for ongoing or completed projects; the certificate is binding on the tax office.

Stage 2 — Assessment by the tax office: After the end of the financial year, the allowance is claimed, assessed and either credited or refunded in the next tax assessment.

The critical success factor is project documentation: time records per project, clear separation from routine development, technical uncertainties documented in writing. Companies that integrate this documentation into their DATEV processes turn the allowance into a recurring revenue component rather than a one-off exercise.

Typical use cases beyond the laboratory

For companies investing in parallel, the allowance works in combination: the declining-balance depreciation under the Immediate Investment Programme front-loads depreciation, while the research allowance reimburses ongoing development costs — together, the strongest tax-based investment incentive currently available.

Frequently Asked Questions

Do companies without a profit also receive the research allowance?

Yes. The allowance is credited against the tax liability; any excess is paid out in cash. Loss-making companies receive the full amount of the funding.

How far back can claims be filed?

The BSFZ certificate can also be applied for in respect of ongoing or already completed projects; the assessment deadlines allow retroactive claims of up to four years.

What counts as eligible development?

Projects involving technical novelty and uncertainty that are pursued systematically — the decisive criteria are those of the OECD Frascati Manual. Purely routine adjustments are excluded.

Fatma Tabak, Steuerberaterin

Fatma Tabak

Tax advisor (Nordbaden Chamber of Tax Advisors) · Founder, TABAK Consulting

More than 20 years advising entrepreneurs, investors and family businesses. Reserved tax services are provided by our partner tax firm, TABAK Steuerberatung.

Firm Profile

Secure your research allowance.

We assess your projects' eligibility, structure the documentation and manage the BSFZ and tax office procedures — including retroactive claims.

Request a Funding Check Related service: AI & Digitalisation